Cargando…
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Autores principales: | Liu, Longlong, Patnana, Pradeep Kumar, Nimmagadda, Subbaiah Chary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166162/ https://www.ncbi.nlm.nih.gov/pubmed/35661690 http://dx.doi.org/10.1038/s41392-022-01040-9 |
Ejemplares similares
-
High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia
por: Liu, Longlong, et al.
Publicado: (2022) -
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
por: Ma, Teng, et al.
Publicado: (2022) -
AMPK promotes lysosomal and mitochondrial biogenesis via folliculin:FNIP1
por: Freemantle, Jordana B, et al.
Publicado: (2023) -
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
por: Xie, Xiaoqing, et al.
Publicado: (2021) -
Bacterial Genes Outnumber Archaeal Genes in Eukaryotic Genomes
por: Brueckner, Julia, et al.
Publicado: (2020)